The short answer
It is not established that folate changes minocycline absorption or that everyone taking minocycline needs extra folate. Review a supplement’s complete ingredients, since any accompanying iron or calcium raises a separate question.
What this answer covers
Folate/vitamin B9 during oral minocycline treatment. Pure folate and mineral-containing multivitamins are distinct.
- Supplement or preparation
- Folate
- Medication ingredient
- minocycline
Check the exact oral medicine
This review concerns oral minocycline. The main tablet label uses minocycline hydrochloride; modified-release capsules have separately stated instructions. Skin foam, dental products and injections do not have the same gut-absorption exposure. Check the release formulation before choosing a schedule.
What the nutrient information actually says
One exact minocycline product document notes increased folic-acid excretion during tetracycline treatment, generally of little clinical significance. This is a nutrient observation, not evidence that taking folate lowers or raises the antibiotic level.
Do not confuse folate with its companion minerals
A folate-only product differs from a prenatal or multivitamin containing iron, calcium or magnesium. The minocycline label and medication-use guidance identify certain mineral products for separation. Those directions should not be assigned to folate itself merely because it appears in the same tablet.
Use an identified nutritional need
Continue folate prescribed for another reason and discuss any concern with the clinician. No exact minocycline-folate study here establishes a new supplement dose or timing interval. Prolonged therapy and poor nutrition may justify individual review, without assuming deficiency or benefit from self-supplementation.
Evidence and practical considerations
Absorption & effectiveness
A class folic-acid excretion observation does not establish altered minocycline exposure, routine folate supplementation or a folate timing interval.
- Exact scope
- Folate/vitamin B9 during oral minocycline treatment. Pure folate and mineral-containing multivitamins are distinct. with RxNorm6980 IN minocycline. Oral hydrochloride label provides explicit active-moiety strengths. Immediate-release tablets are distinguished from MINOCIN MR capsules, topical foam, periodontal products and injection.
- Medication form and route
- Oral
What remains uncertain
- No exact folate co-use PK or supplementation-benefit trial identified. Class excretion observation described as generally of little clinical significance; mineral-combination effects must be separated.
Factors that may matter: Exact oral release formulation; Mineral salt and combination ingredients; Dosing order and meals; Treatment indication.
Read the supporting source summaries
Source 1: Current original prescribing information
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients prescribed the specified oral formulation.
Warns mineral antacids and iron impair absorption. Dairy-containing meal caused only small exposure reduction; tablets may be taken with or without food.
How this applies: RxNorm6980 IN minocycline. Oral hydrochloride label provides explicit active-moiety strengths. Immediate-release tablets are distinguished from MINOCIN MR capsules, topical foam, periodontal products and injection.
Class interaction wording within exact label does not measure every salt. MR timing cannot be automatically transferred to all formulations.
Source 2: Original medication-use guidance
medlineplus.gov · Source check Sep 10, 2026
Population: Users of oral minocycline.
For listed antacids/calcium/magnesium laxatives: one or two hours either side; iron product three hours before or two after minocycline. Product-specific MR directions differ.
How this applies: RxNorm6980 IN minocycline. Oral hydrochloride label provides explicit active-moiety strengths. Immediate-release tablets are distinguished from MINOCIN MR capsules, topical foam, periodontal products and injection.
Practical guidance, not a trial proving every listed interval restores exposure. Direction and formulation matter.
Source 3: Original regulatory product information
geneesmiddeleninformatiebank.nl · Source check Sep 10, 2026
Population: People receiving oral minocycline.
Reports increased folic-acid excretion during tetracycline treatment as generally of little clinical significance and lists reduced vitamin levels with unknown frequency.
How this applies: Distinguishes nutrient biomarker direction from antibiotic absorption and patient benefit.
Class observation in an exact-drug monograph, not an exact folate supplementation trial or evidence that folate reduces minocycline exposure.
Source 4: Medication terminology
rxnav.nlm.nih.gov · Source check Sep 10, 2026
Population: Terminology.
minocycline is IN.
How this applies: Exact ingredient.
Not clinical evidence.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Research summary published | |
| Article prepared | |
| Sources checked and article drafted. |
Article revision: 108da1cada94d9ce
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.